Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study
Authors
Sumaiah J. Alarfaj (ORCID: https://orcid.org/0000-0002-3144-8305)
M Maher (ORCID: https://orcid.org/0000-0001-6540-3650)
Amsha S. Alsegiani (ORCID: https://orcid.org/0000-0003-2463-3606)
Sarah Alrubia (ORCID: https://orcid.org/0000-0003-1892-2452)
Sahar K. Hegazy (ORCID: https://orcid.org/0000-0002-4516-926X)
Thanaa A. El‐Masry
Mostafa M. Bahaa (ORCID: https://orcid.org/0000-0003-3332-4573)
Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study
Sumaiah J. Alarfaj, M Maher, Amsha S. Alsegiani, Sarah Alrubia et al.
Citations
5 citations
Journal
Frontiers in Medicine
Topics
Inflammasome and immune disorders
Field-Weighted Citation Impact (FWCI)
4.03
article
Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study
Sumaiah J. Alarfaj, M Maher, Amsha S. Alsegiani, Sarah Alrubia, Sahar K. Hegazy, Thanaa A. El‐Masry, Mostafa M. Bahaa, Sahar M. El-Haggar, Monir M. Bahgat
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in MedicineVol. 11
Institutions
Princess Nourah bint Abdulrahman University (SA), Damietta University (EG), Mansoura University (EG), Tanta University (EG), King Saud University (SA)